231![I. CANCER DE MAMA 1. Implication of miRNA in the diagnosis and treatment of breast cancer. Castañeda CA, Agullo-Ortuño MT, Fresno Vara JA, Cortes-Funes H, Gomez HL, Ciruelos E. I. CANCER DE MAMA 1. Implication of miRNA in the diagnosis and treatment of breast cancer. Castañeda CA, Agullo-Ortuño MT, Fresno Vara JA, Cortes-Funes H, Gomez HL, Ciruelos E.](https://www.pdfsearch.io/img/595c10316e24de5e1eb764e5dbf2f3bb.jpg) | Add to Reading ListSource URL: www.inen.sld.peLanguage: English - Date: 2014-03-13 18:40:54
|
---|
232![AFTER HOURS PLUS MEDICATIONS – INFORMATION SHEETS *While the ‘active ingredient’ of medications provided to After Hours Plus members is consistent, the brand may vary depending on location. If the brand provided by AFTER HOURS PLUS MEDICATIONS – INFORMATION SHEETS *While the ‘active ingredient’ of medications provided to After Hours Plus members is consistent, the brand may vary depending on location. If the brand provided by](https://www.pdfsearch.io/img/26508b26d416943dda5b1a73dbcf546c.jpg) | Add to Reading ListSource URL: afterhoursplus.homedoctor.com.auLanguage: English - Date: 2015-04-09 23:54:19
|
---|
233![Astex Achieves Milestones in GSK Collaboration Cambridge, UK, 3rd May[removed]Astex Therapeutics, the UK-based biotechnology company developing targeted therapies for oncology and virology, announced that it has achieved m Astex Achieves Milestones in GSK Collaboration Cambridge, UK, 3rd May[removed]Astex Therapeutics, the UK-based biotechnology company developing targeted therapies for oncology and virology, announced that it has achieved m](https://www.pdfsearch.io/img/f5760014d3f9feefb61cda8e95a1e7c0.jpg) | Add to Reading ListSource URL: astx.comLanguage: English |
---|
234![Essays of an Information Scientist: Creativity, Delayed Recognition, and other Essays, Vol:12, p.201, 1989 Current Contents, #30, p.3-13, July 24,1989 I I Essays of an Information Scientist: Creativity, Delayed Recognition, and other Essays, Vol:12, p.201, 1989 Current Contents, #30, p.3-13, July 24,1989 I I](https://www.pdfsearch.io/img/d23b835ed79459dd58ddf0a8eba94d85.jpg) | Add to Reading ListSource URL: www.garfield.library.upenn.eduLanguage: English - Date: 1999-10-01 12:25:55
|
---|
235![Package leaflet: Information for the user Nimenrix® powder and solvent for solution for injection in pre-filled syringe Meningococcal group A, C, W-135 and Y conjugate vaccine ▼ This medicine is subject to additional Package leaflet: Information for the user Nimenrix® powder and solvent for solution for injection in pre-filled syringe Meningococcal group A, C, W-135 and Y conjugate vaccine ▼ This medicine is subject to additional](https://www.pdfsearch.io/img/80ca753cb9f5da4fb4294f623b15af01.jpg) | Add to Reading ListSource URL: www.medicines.org.ukLanguage: English |
---|
236![AMOXYCILLIN ChAMP Monographs DESCRIPTION ChAMP AMOXYCILLIN ChAMP Monographs DESCRIPTION ChAMP](https://www.pdfsearch.io/img/978fa9be0b5b0085515eabc8d8fb29a1.jpg) | Add to Reading ListSource URL: kidshealthwa.comLanguage: English - Date: 2014-02-13 02:52:37
|
---|
237![EAR, NOSE,THROAT and DENTAL Sinusiits Ear infections EAR, NOSE,THROAT and DENTAL Sinusiits Ear infections](https://www.pdfsearch.io/img/3da7ac84107709c185a41229c3f15b21.jpg) | Add to Reading ListSource URL: kidshealthwa.comLanguage: English - Date: 2014-02-13 02:14:59
|
---|
238![CEFUROXIME ChAMP Monographs DESCRIPTION ChAMP INDICATIONS AND CEFUROXIME ChAMP Monographs DESCRIPTION ChAMP INDICATIONS AND](https://www.pdfsearch.io/img/14cbcaf8dcaf267e16c0c1f033f2aa26.jpg) | Add to Reading ListSource URL: kidshealthwa.comLanguage: English - Date: 2014-02-13 02:53:45
|
---|
239![WIPO Re:Search Agreements in Place as of Feb. 11, 2015 Year Provider WIPO Re:Search Agreements in Place as of Feb. 11, 2015 Year Provider](https://www.pdfsearch.io/img/caddbb8f194b90f80ea1579cd9df84b8.jpg) | Add to Reading ListSource URL: www.wipo.intLanguage: English - Date: 2015-02-14 03:36:37
|
---|
240![Translation Taisho Pharmaceutical Co., Ltd. Chugai Pharmaceutical Co., Ltd. Results of Phase III Clinical Trial of Ibandronate Sodium Hydrate Oral Formulation, Bisphosphonate Antiresorptive Agent, Translation Taisho Pharmaceutical Co., Ltd. Chugai Pharmaceutical Co., Ltd. Results of Phase III Clinical Trial of Ibandronate Sodium Hydrate Oral Formulation, Bisphosphonate Antiresorptive Agent,](https://www.pdfsearch.io/img/080b9ed2f6415a2388c1f7ed89a45bbe.jpg) | Add to Reading ListSource URL: www.taisho.co.jpLanguage: English - Date: 2015-03-29 22:30:34
|
---|